Digicann Ventures Inc.
Digicann Ventures Inc.
Your view on AGFAF
Overview
What the company does, where it operates, and who runs it.
About Digicann Ventures Inc.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Nicholas J. Kuzyk
- Headquarters
- 789 West Pender Street, Vancouver, BC, CA
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Nicholas J. Kuzyk
- Headquarters
- 789 West Pender Street, Vancouver, BC, CA
Digicann Ventures Inc., together with its subsidiaries, operates in the cannabis industry. The company was formerly known as Agra Ventures Ltd. and changed its name to Digicann Ventures Inc. in August 2023. Digicann Ventures Inc. was incorporated in 2004 and is headquartered in Vancouver, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Digicann Ventures Inc., and the rating behind it. AGFAF last traded at $0.03; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Digicann Ventures Inc.. Starting points for Digicann Ventures Inc.: EPS -$0.74, beta 2.34 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Digicann Ventures Inc.. Digicann Ventures Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Digicann Ventures Inc.. Trailing twelve-month EPS for Digicann Ventures Inc. stands at -$0.74. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Digicann Ventures Inc.. Digicann Ventures Inc. has reported as a listed company since 2015. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Digicann Ventures Inc. valued side by side against its closest peers. Digicann Ventures Inc. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Digicann Ventures Inc., and how their positions are changing. At a $606,354 market value, institutional positions materially move Digicann Ventures Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Digicann Ventures Inc. executives and directors. Shares of Digicann Ventures Inc. have traded between $0.0002 and $0.05 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Digicann Ventures Inc.. Digicann Ventures Inc. is a $606,354 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Digicann Ventures Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Digicann Ventures Inc.. Coverage tracks Digicann Ventures Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.